Terminated due to low accrual.
Effectiveness of HEPA-filtered Rooms ("Protected Environment") to Prevent Morbidity and Mortality in Patients Age >/ = 60 Receiving Lower Intensity ("Targeted") Therapy for Untreated AML and High-risk Myelodysplasia (MDS)
Sponsor study identifier
observational
3
1 country
1
Study Start
January 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2008
Actual (reported)Study Completion
January 2008
Actual (reported)The goal of this clinical research study is to learn if the "protected environment" (PE) can help to prevent infections in patients aged 60 and above who are receiving what is considered low-intensity treatment for newly-diagnosed AML or high-risk MDS.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2008
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2007
Date type not reportedThis date has not been verified as actual or estimated.
March 1, 2007
Actual (reported)March 5, 2007
Actual (reported)January 2008
Actual (reported)January 2008
Actual (reported)Success Rate
Success is defined as number of participants with no death, pneumonia, or sepsis within 6 weeks of randomization compared to total number of participants to evaluate effect of the protected environment (PE) by (adaptively) randomly assigning patients age \>/= 60 given targeted therapies between treatment inside or outside the PE.
Baseline to 6 weeks post randomization to PE or Non PE
Participants in a Protective environment
Participants not in a protective environment
Patients with AML or high-risk MDS Age \>/= 60 years with a Zubrod performance status of 0,1, or 2
UT MD Anderson Cancer Center
Houston, Texas, 77030, United States
Gloria N. Mattiuzzi, MD
M.D. Anderson Cancer Center
3 participants (actual enrollment reported by the registry).
First Submitted
March 1, 2007
First Posted
March 5, 2007
Study Start
January 2007
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Primary Completion
January 2008
Actual (reported)Study Completion
January 2008
Actual (reported)Last Updated
August 2, 2012
Record last verified: 2012-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: